Search All UT System Experts

Phase II study of mitomycin, doxorubicin, and cisplatin in the treatment of advanced uterine leiomyosarcoma: A Gynecologic Oncology Group study

John H. Edmonson, John A. Blessing, Jonathan A. Cosin, David Scott Miller, David E. Cohn, Jacob Rotmensch

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of mitomycin, doxorubicin, and cisplatin in the treatment of advanced uterine leiomyosarcoma: A Gynecologic Oncology Group study'. Together they form a unique fingerprint.

Medicine & Life Sciences